Biote (BTMD) Cash from Financing Activities (2021 - 2026)

Biote's Cash from Financing Activities history runs 6 years deep, the most recent figure standing at -$21.5 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities fell 854.32% year-over-year to -$21.5 million; the TTM figure through Mar 2026 stood at -$62.8 million (up 13.84% YoY), while the FY2025 annual figure was -$43.6 million, up 42.75% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at -$21.5 million, down from -$9.1 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $84.3 million in Q2 2022, with the low at -$59.0 million in Q2 2024.
• The 5-year median for Cash from Financing Activities is -$5.1 million (2023), against an average of -$5.4 million.
• The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities soared 125.57% in 2022, then slumped 1065.92% in 2024.
• Biote's Cash from Financing Activities stood at -$4.0 million in 2022, then soared by 36.49% to -$2.5 million in 2023, then slumped by 293.43% to -$9.9 million in 2024, then rose by 8.08% to -$9.1 million in 2025, then tumbled by 135.89% to -$21.5 million in 2026.
• Business Quant data shows BTMD's Cash from Financing Activities at -$21.5 million in Q1 2026, -$9.1 million in Q4 2025, and -$4.9 million in Q3 2025.